Trial Profile
Effect of Sabril on seizure control of children with interactable epilepsy admitted to Mofid hospital -
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Sep 2016
Price :
$35
*
At a glance
- Drugs Vigabatrin (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 17 Dec 2012 New trial record
- 01 Oct 2012 Recruitment completed.